A Phase I Study to Assess the Safety and Immunogenicity of DNK-651 in Japanese Healthy Young Adults and Elderly Adults

Trial Profile

A Phase I Study to Assess the Safety and Immunogenicity of DNK-651 in Japanese Healthy Young Adults and Elderly Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms DNK-651-1
  • Sponsors Denka Seiken
  • Most Recent Events

    • 29 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 18 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top